Chemical Composition, Antibacterial and Antibiotic-Modifying Activity of Croton grewioides Baill Essential Oil

Abstract

Background: Croton grewioides Baill., a species native to the Caatinga, popularly known as canela de cunhã, is used in traditional medicine to treat gastrointestinal diseases such as diarrhea, gastritis and stomach ulcers. The combination of essential oils with antibiotics reveals several beneficial effects associated with the increased efficacy of these drugs against pathogenic agents. Through this perspective, this study aimed to identify the chemical composition of the essential oil of C. grewioides (OECG) and evaluate its antibacterial and antibiotic-modifying activities against standard and multiresistant bacteria. Methods: To analyze the compounds present in the oil, the techniques of gas chromatography coupled with mass spectrometry (GC/MS) and gas chromatography with a flame ionization detector (GC/FID) were used. In the bacteriological tests, the Minimum Inhibitory Concentration (MIC) was obtained by the broth microdilution technique. The modulating effect of the essential oil was determined by calculating the subinhibitory concentration, followed by a serial microdilution of the antibiotics. The MIC reduction factor (CRF) was calculated, and its data were expressed as a percentage. Results: The analysis of the chemical composition identified the presence of the major compound estragole with a relative abundance of 50.34%. The MIC values obtained demonstrated efficacy in K. pneumoniae isolated from urine with MIC values of 512 µg/mL. OECG potentiated the effects of all antibiotics tested on the strains S. aureus ATCC 29213, K. pneumoniae Carbapnemase, E. coli ATCC 25922 and S. aureus ATCC 29213 with their CRF of 97.65%, 99.80%, 99.85% and 99.88%, respectively. Conclusions: Thus, the essential oil of C. grewioides presents synergistic effects when combined with the antibiotics tested, in addition to acting in the fight against bacterial resistance to antibiotics.

1. Introduction

The discovery of antibiotics led to a reduction in mortality rates caused by bacterial infections in hospital settings. However, the widespread and uncontrolled use of these drugs has promoted the emergence of resistant microorganisms [1], making research into natural products a promising alternative for combating microbial resistance [2].

In Brazil, the native fauna and flora have been used since before colonization by native peoples to treat illnesses, accumulating enormous knowledge of medicinal flora [3]. Despite having one of the greatest biodiversities in the world, research on native products of Brazilian flora is relatively underdeveloped [4]. Among the Brazilian biomes, the Caatinga encompasses a large number of plant species with therapeutic potential, but few studies have focused on the area of chemistry. Therefore, research on species from the Caatinga is still in its infancy, and their use is reserved, in most cases, for use by traditional and local communities [5].

The species Croton grewioides Baill. (Euphorbiaceae), commonly known as canela de cunhã, is widely distributed throughout the Nordeste region of Brazil and is characteristic of the Caatinga biome [6]. Its use in traditional medicine is through teas and infusions of fresh leaves, commonly used in the treatment of gastrointestinal disorders such as diarrhea, gastritis and in the treatment of stomach ulcers, in addition to being used as a sedative agent, relieving pain symptoms and having a calming effect [7,8,9,10,11]. Its anti-inflammatory, hepatoprotective and insecticidal effect is also reported, used by small and medium-sized farmers for pest control [12]. These reported activities are likely associated with the chemical constituents anethole and estragole, which are present in the essential oil of the leaves of C. grewioides.

Several studies report that the association of essential oils with antibiotics brings with it beneficial effects in their use, such as increasing the efficacy of these drugs, which leads to a reduction in the pathogenicity of the tested strains [13,14,15]. Thus, given the high prevalence of antibiotic-resistant microorganisms and the limited microbiological studies on C. grewioides, this study aimed to identify the chemical composition of the essential oil of C. grewioides and evaluate its antibacterial and modifying activities of beta-lactam antibiotics (amoxicillin and penicillin) and aminoglycosides (gentamicin and amikacin) against standard and multidrug-resistant bacteria.

2. Materials and Methods

2.1. Collection and Obtaining of Essential Oil

Aerial parts of C. grewioides were collected in the municipality of Crato, Ceará-Brazil, between August and September 2022 in the morning. A specimen was deposited in the Herbarium Caririense Dárdano de Andrade Lima of the Regional University of Cariri, where it was assigned registration number 1619. The essential oil was obtained by hydrodistillation (Clevenger type apparatus, Spalabor Instruments Inc., Presidente Prudente, SP, Brazil), where the sample of the dry plant material (2 kg) was crushed and subjected to distillation for 4 h. The obtained oil was dried over Na₂SO₄, yielding 0.20% (w/w).

2.2. GC-MS Analysis

GC-MS was performed with a Shimadzu GC-MS QP2010 series (Shimadzu Scientific Instruments Inc., Columbia, MD, USA). The compounds present in the essential oil of C. grewioides were separated on a capillary column SH-Rtx-5 (30 m × 0.25 mm I.D. × 0.25 mm film). The analysis time was 30 min and followed the following temperature program: 80–180 °C at 4 °C/min, then to 246 °C at 6.6 °C/min, closing with 10 min at 280 °C, at 3.4 °C/min. Helium was used as a carrier gas; the injector temperature was 220 °C; the flow rate was 1.5 mL/min; and the split ratio was 1:100. The MS detection conditions were as follows: interface temperature, 230 °C and íon source, 200 °C; Ionization mode, EI; electron energy, 70 eV; mass range, 40–350 m/z. Compounds were identified by the use of online NIST-library spectra and literature MS data. The results were expressed as mean area (%) ± standard deviation (n = 3).

2.3. GC Analysis

GC analysis was performed with a Shimadzu GC-2010 Plus equipped with FID (Shimadzu Scientific Instruments Inc., Columbia, MD, USA). Compounds were separated on 30 m × 0.25 mm i.d. × 0.25 mm film SH-Rtx-5 capillary column. The analysis was performed in 30 min, according to the following temperature program: 80–180 °C at 4 °C/min, then to 246 °C at 6.6 °C/min, closing with 10 min at 280 °C, at 3.4 °C/min. A split injection was conducted with a split ratio of 1:15; flow rate: 1.5 mL/min; injection volume: 1 µL of 500 ppm solution prepared with dichloromethane; and helium was used as carrier gas. The linear retention index was obtained by injecting a mixture of C8–C40 linear hydrocarbons under the same conditions as the samples, as described by Van Den Dool and Kratz (1963). The identity of the compounds was confirmed by comparing their retention indices and mass spectra with those taken from the literature [16].

2.4. Antibacterial Activity

2.4.1. Determination of Minimum Inhibitory Concentration (MIC)

To determine the antibacterial activity, the broth microdilution method containing the Brain Heart Infusion Broth (BHI) culture medium was used based on the CLSI document [17]. The following strains were used: Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213, Klebsiella pneumoniae Clinical Urine Isolate (ICU), Escherichia coli 06, Staphylococcus aureus 10, Klebsiella pneumoniae Carbapnemase (KPC) and Klebsiella pneumoniae Betalactamase (BLSE).

The essential oil of C. grewioides (OECG) was prepared at a concentration of 1024 µg/mL diluted in sterile water and DMSO. In the assay, serial microdilutions of 100 µL of OECG were performed where the control group contained only the inoculum. The tests were conducted in triplicate and incubated in the microbiological incubator at 37 º C for 24 h. The readings were performed by the colorimetric method using 25 µL of 0.01% sodium resazurin [17].

2.4.2. Antibiotic Modulation Tests

The antibiotics used to evaluate the OECG modulating activity were amoxicillin, penicillin, gentamicin and amikacin. The methodology for performing the test was adapted from Coutinho et al. [18]. Based on the calculation of subinhibitory concentrations (MIC/8), a serial microdilution of the respective antibiotics was performed. The negative control contained only OECG and the inoculum, and the positive control contained the antibiotics and the bacterial inoculum. The tests were performed in triplicate, where the plates were placed in an incubator at 37 °C for 24 h, and then the bacterial growth was evaluated by the colorimetric method with sodium resazurin (0.01%).

2.4.3. Determination of the MIC Reduction Factor

To determine the MIC Reduction Factor (FRC) expressed as a percentage, the value of X was calculated using the formula below. To perform this calculation, a simple rule of three was used, which obtained the following conclusions: X is equal to the values of the test MIC (which contains the essential oil together with the antibiotic) multiplied by the value of 100 divided by the values of the control MIC (antibiotics and bacteria). Thus, the values obtained in the CRF calculation represent the percentage of reduction in the MIC values in the presence of the essential oil.

FRC = 100 − X

X = CIM test × 100/CIM control

FCR = 100 − (CIM test × 100/CIM control)

2.4.4. Statistical Analysis

The tests were analyzed by two-way ANOVA followed by the Bonferroni test using GranphPad Prism 10.0 software (accessed on 10 June 2024). Results expressed at p < 0.05 were considered statistically significant.

3. Results and Discussion

3.1. Composition of C. grewioides Essential Oil

The evaluation of the chemical composition of the essential oil extracted from the aerial parts of C. grewioides revealed the presence of 2.92% of monoterpenoid compounds, 5.45% of oxygenated monoterpenes, 4.40% of sesquiterpenes, 0.42% of oxygenated sesquiterpenes, 69.73% of phenylpropanoids and 10.99% of ethers. The major compound identified in the chemical analysis was estragole with 50.34%, followed by the compounds methyl eugenol with 19.39% and anisole with 10.99%. In total, 18 compounds were identified by chromatography analysis (Figure 1 and Figure 2), whose percentages are described in

Table 1. Compounds identified (GC/MS) in the essential oil of the aerial parts of C. grewioides.

No.	Compounds	Mean ± Standard Deviation (%)	RT (min)	IR 1	IR 2
1	α-pinene	0.766 ± 0.092	3.973	1.070	1.050
2	camphene	0.413 ± 0.050	4.141	1.090	1.097
3	sabinene	0.250 ± 0.127	4.380	1.111	1.123
4	2-β-pinene	0.243 ± 0.125	4.455	1.116	1.119
5	β-myrcene	0.400 ± 0.173	4.530	1.122	1.142
6	1,8-cineole	4.650 ± 0.412	5.016	1.156	1.164
7	β-ocimene	1.336 ± 0.219	5.156	1.165	1.145
8	camphor	1.143 ± 0.164	6.094	1.223	1.243
9	isoborneol	0.146 ± 0.020	6.345	1.236	1.255
10	estragole	49.61 ± 0.688	6.539	1.246	1.226
11	anisole	11.36 ± 0.352	7.250	1.283	1.264
12	methyl eugenol	19.05 ± 0.653	8.108	1.339	1.359
13	β-elemene	1.286 ± 0.111	8.318	1.355	1.375
14	trans-caryophyllene	0.826 ± 0.020	8.645	1.380	1.400
15	isoledene	0.290 ± 0.069	8.800	1.391	1.373
16	methyl-trans-isoeugenol	6.340 ± 0.485	8.943	1.403	1.422
17	caryophyllene oxide	1.750 ± 0.243	10.357	1.553	1.572
18	α-selinene	0.287 ± 0.090	11.326	1.628	1.648

Results expressed as the average area of each compound (%) ± DP (n = 3). RT: Retention time (min); IR ¹: Linear retention index obtained; IR ²: Linear retention index obtained from the literature.

.

In a study conducted by Santos et al. [19] that evaluated the chemical composition of essential oils from three chemotypes of C. grewioides extracted from branches, in the first chemotype, the major component was (E)-anethole with 70.5%. In the second chemotype, the major component was eugenol with 84.2%. Finally, in the third chemotype, (Z)-methyl with 53.4% was presented. In another study carried out by Silva et al. [17], the composition of the essential oil of C. grewioides extracted from branches revealed (E)-anethole as the major component with 47.8%. Comparing these studies with the components identified in this research, the absence of the compound (E)-anethole in the chromatographic analyses is demonstrated, which can be explained by environmental factors such as collection site, collection period, part of the plant used, vegetative state of the plant, genetic factors, among others [20,21,22].

Studies evaluating the chemical composition of the essential oil extracted from the leaves of C. grewioides, reported by Costa et al. [23] and Siqueira et al. [24] reveal the presence of estragole with 76.8% and 45.95%, respectively, as the major components present in its oil. As in the studies conducted by Leite et al. [25] and Andrade et al. [8], its percentage present in the essential oil is 78% and 84.7%, whose estragole compound and its percentages are close to those found in this study.

The variation in the chemical composition of essential oils is likely a result of the plant’s adaptive mechanisms, which utilize secondary metabolites to defend against predators and to adapt to variations in both biotic and abiotic environmental conditions [26].

3.2. Antibacterial Activity

The antibacterial activity of C. grewioides essential oil tested on standard strains demonstrated significant results against the K. pneumoniae (ICU) strain with an MIC value of 512 µg/mL. In multidrug-resistant strains, the oil presented better results on the K. pneumoniae (KPC) and K. pneumoniae (BLSE) strains, with MIC values of 512 and 256 µg/mL, respectively. The other MIC values of the strains used in this study are described in

Table 2. Minimum Inhibitory Concentration (MIC) values of OECG against standard and multiresistant bacteria.

	Organisms	MIC (µg/mL)
Multidrug-resistant strains	SA 10	≥1024
	EC 06	≥1024
	KPC	512
	KP BLSE	256
Standard strains	EC 25922	≥1024
	SA 29213	≥1024
	KP ICU	512

SA 10—S. aureus 10; EC 06—E. coli 06; KP BLSE—K. pneumoniae BLSE; KPC—K. pneumoniae Carbapenemáse; KP ICU—K. pneumoniae clinical urine isolate; SA 29213—S. aureus ATCC 29213; and EC 25922—E. coli ATCC 25922.

.

In the strains tested, there was no inhibition of bacterial growth even at a concentration of 1024 µg/mL of OECG. This lack of inhibition was due to the fact that the strains tested present biochemical mechanisms related to bacterial resistance, which implies a high degree of pathogenicity, since the strains tested in this study are involved in various infections in hospitalized patients, mainly due to urinary tract infections, as is the case with strains of E. coli and K. pneumoniae [27].

Studies such as those by Rodrigues and collaborators [28], which demonstrate the antibacterial potential of the C. grewioides essential oil against standard strains of Pseudomonas aeruginosa ATCC 15442 and S. aureus ATCC 12692, obtained minimum inhibitory dose (MID) results of 1 and 0.5 mg/L of air in S. aureus. These findings corroborate the results obtained in this research, suggesting that compounds present in the essential oil, such as estragole and anethole, which are commonly reported in chemical studies, are directly related to the antibacterial effects observed in the tests.

3.3. Modulating Activity

The beta-lactam antibiotics used in this study were amoxicillin and penicillin, which have a mechanism of action associated with the inhibition of bacterial cell wall synthesis, leading to a destabilization of the cell wall’s macrostructure and leakage of intracellular fluid due to membrane lysis. The aminoglycoside antibiotics were amikacin and gentamicin, which act by inhibiting the protein synthesis mechanism, specifically in the 30S subunit of bacterial ribosomes [29].

From the results obtained in the modulation tests, OECG enhanced the effects of amoxicillin on strains of S. aureus 10, K. pneumoniae (ICU) and S. aureus ATCC 29213, with their respective MIC Reduction Factors (FRC) of 85%, 84.16% and 97.65%. As for penicillin, it presented results on strains of S. aureus 10 and S. aureus ATCC 29213, with its most potent effects on K. pneumoniae (KPC) with an FRC of 99.95%, E. coli 06 with 99.80% and K. pneumoniae (ICU) with 98.02%. The remaining results are detailed in

Table 3. Minimum inhibitory concentrations (µg/mL) of antibiotics in the absence and presence of C. grewioides essential oil and their MIC reduction factors (FRC).

Substance	Organisms	MIC of Antibiotics (µg/mL)
		Amoxicillin	Penicillin	Gentamicin	Amikacin
Control	SA 10	40	8	8	40
	EC 06	40	256	8	40
	KP BLSE	256	1024	1024	32
	KPC	645	1024	812	512
	KP ICU	101	406	203	161
	SA 29213	256	256	128	256
	EC 25922	256	512	203	128
OECG test	SA 10	6	0.5	0.5	2
	EC 06	161	0.5	0.5	3
	KP BLSE	256	1024	256	161
	KPC	1024	0.5	1024	512
	KP ICU	16	8	0.5	4
	SA 29213	6	40	0.25	0.30
	EC 25922	203	512	0.30	20
FRC	SA 10	85%	93.75%	93.75%	95%
	EC 06	−302.5%	99.80%	93.75%	92.5%
	KP BLSE	0%	0%	75%	−403.12%
	KPC	−58.76%	99.95%	−26.10%	0%
	KP ICU	84.16%	98.02%	99.75%	97.51%
	SA 29213	97.65%	84.37%	99.80%	99.88%
	EC 25922	20.7%	0%	99.85%	84.37%

SA 10—S. aureus 10; EC 06—E. coli 06; KP BLSE—K. pneumoniae BLSE; KPC—K. pneumoniae Carbapenemáse; KP ICU—K. pneumoniae clinical urine isolate; SA 29213—S. aureus ATCC 29213; EC 25922—E. coli ATCC 25922; OECG—C. grewioides essential oil; FRC—MIC reduction factor.

.

When associated with gentamicin, OECG demonstrated promising results in both standard and multidrug-resistant strains, except for K. pneumoniae (KPC), which presented a negative FRC, indicating an antagonistic effect. Of these results, the standard strains obtained an FRC of 99.85% in E. coli ATCC 25922, 99.80% in S. aureus ATCC 29,213 and 99.75% in K. pneumoniae (ICU). As for amikacin, OECG was more effective against S. aureus ATCC 29,213 with an FRC of 99.88%.

In the graph shown in Figure 3, the modulating effect of OECG associated with the antibiotic amoxicillin against the strains used in this study and a synergistic effect were observed in the multiresistant strain S. aureus 10, and in all standard strains tested. In the other strains tested, an antagonistic effect was observed in S. aureus 10, E. coli 06, K. pneumoniae (BLSE), K. pneumoniae (KPC).

OECG also showed synergistic effects in association with penicillin. Figure 4 demonstrates the synergistic effects in all strains tested, with the exception of K. pneumoniae (BLSE) and E. coli ATCC 29213, which showed an equivalence of means. One of the main mechanisms of bacterial resistance to beta-lactam antibiotics is the production of the beta-lactamase enzyme that hydrolyzes the beta-lactam ring of these antibiotics, inhibiting their action [30]. The lack of effects of OECG associated with penicillin against K. pneumoniae (BLSE) may be related to its resistance mechanism of the type of producer of the beta-lactamase enzyme that acts to inhibit the action of these drugs [31].

Carbapinemase-producing bacteria exhibit a broad resistance mechanism against several beta-lactam antibiotics, acting in the hydrolysis of drugs such as penicillin, cephalosporins, monobactams and carbapenems [32,33]. In this study, OECG potentiated the effect of penicillin, providing evidence that it may be involved in increasing membrane permeability, in which the entry of the drug into the cell is facilitated, in addition to acting at the genetic level, altering its resistance mechanism, since the drug is able to enter the cell, overcoming enzymatic barriers and inhibiting peptidoglycan synthesis, leading to the rupture and extravasation of intracellular content [34].

Amoxicillin, which also acts to inhibit cell wall synthesis, showed synergism in standard strains and multiresistant S. aureus 10. The mechanism is similar to that of penicillin. Furthermore, more effective inhibition by the drug was expected in standard strains, since these do not have as many resistance mechanisms as multiresistant strains.

In corroboration with these data, Medeiros et al. [35] evaluated the effects of the C. grewioides essential oil on the modulation of the antibiotics norfloxacin and tetracycline against Staphylococcus aureus (SA-1199B) with the efflux pump resistance mechanism, and they demonstrated that in the absence of the oil, the antibiotic presents an inhibitory concentration of 64 µg/mL for norfloxacin and 32 µg/mL for tetracycline. In the presence of the oil, these values dropped to 16 µg/mL for norfloxacin and 0.5 µg/mL for tetracycline, enhancing the effect of the antibiotic, even in the presence of the overexpressed gene for the efflux pump.

The effect of OECG against aminoglycoside antibiotics showed that amikacin (Figure 5) presented synergistic effects in all strains tested except K. pneumoniae (BLSE), which presented an antagonistic effect, and K. pneumoniae (KPC), which demonstrated equivalence to the control. As for gentamicin (Figure 6), synergistic effects were observed in all strains tested, except for K. pneumoniae (KPC), which exhibited an antagonistic effect.

Protein synthesis inhibitors that act on bacterial ribosomes in the 30S and 50S subunits are mainly classified as aminoglycosides, tetracyclines, and aphenicols, among others. These antibacterial drugs have greater selectivity precisely because they target components of the bacterial ribosome that are distinct from those of eukaryotic ribosomes [29]. For amikacin, promising results were observed in both standard and multidrug-resistant strains, with synergistic effects reported in all standard strains as well as in the multidrug-resistant E. coli 06 and S. aureus 10.

Essential oils, due to their hydrophobic nature, interfere in essential biochemical processes for the cell when they come into contact with bacterial membranes, such as the respiratory chain and energy production, which leads to the deregulation of membrane permeability, facilitating the entry of antibiotic drugs, in addition to interfering in the efflux pump resistance mechanism, since this requires the binding of the adenosine triphosphate (ATP) molecule for its functioning in the “expulsion” of toxic substances [28,36].

Linked to the hydrophobic character of essential oils, their effects on the antibacterial and modulating activity reported in this research may be related to the various compounds of the terpene class present in their composition that have an intrinsic relationship to this activity [37].

4. Conclusions

The data obtained in this research allow us to conclude that OECG, when associated with the tested antibiotics, increased its efficacy in the main strains of clinical relevance, with the most promising effects observed in E. coli 06, K. pneumoniae (KPC), S. aureus ATCC 29213 and E. coli ATCC 25922. Thus, OECG has the potential to be used in future antimicrobial therapies, acting as a modulating agent in the fight against bacterial resistance to antibiotics. However, further research on its action on the permeability of the bacterial membrane, genetic alterations of its resistance mechanism, in addition to analyses of isolated compounds are necessary to verify whether the efficacy of the essential oil is linked to the major compound and thus able to use it in future antibacterial treatments.